| Kathryn Mariah Nomura, MS, LPC | |
|
5638 Medical Center Dr, Katy, TX 77494-6325 | |
| (281) 392-7505 | |
| Not Available |
| Full Name | Kathryn Mariah Nomura |
|---|---|
| Gender | Female |
| Speciality | Counselor - Mental Health |
| Location | 5638 Medical Center Dr, Katy, Texas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053446468 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YM0800X | Counselor - Mental Health | 20284 (Texas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Kathryn Mariah Nomura, MS, LPC 12915 Shady Knoll Ln, Cypress, TX 77429-2211 Ph: (713) 530-7585 | Kathryn Mariah Nomura, MS, LPC 5638 Medical Center Dr, Katy, TX 77494-6325 Ph: (281) 392-7505 |
News Archive
Researchers in China have developed three SARS-CoV-2 nanoparticle vaccines, containing receptor-binding domain (RBD) trimer, S1 trimer, and ectodomain (ECD) trimer, respectively. To do this, they have used Ferritin nanoparticle self-assembly technology.
Local United Auto Workers leaders representing Ford Motor employees on Monday by voice vote unanimously approved a tentative four-year contract agreement that follows the pattern set by General Motors and Chrysler Group and includes the creation of a voluntary employees' beneficiary association, the AP/Philadelphia Inquirer reports (Krisher/Durbin, AP/Philadelphia Inquirer, 11/6).
Stemline Therapeutics, Inc. today announced that data from pre-clinical studies of its IL-3R targeting agents, SL-401 and SL-501, in both in vitro and animal models of human chronic myeloid leukemia (CML) have been selected for poster presentation at the upcoming 51st Annual Meeting of the American Society of Hematology (ASH), to be held in New Orleans from December 5-8, 2009.
Results from a new study led by Boston Medical Center (BMC) indicate that, when performed appropriately, chemical peels can be a safe treatment option for people with darker skin.
ARIAD Pharmaceuticals, Inc. today announced the initiation of the Phase 2 trial of Iclusig (ponatinib) in adult patients with metastatic and/or unresectable gastrointestinal stromal tumors.
› Verified 8 days ago
Mrs. Melissa Diane Barton, MA, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 5608 5th St, # B-2, Katy, TX 77493 Phone: 832-372-5900 | |
Dianna Mae Kinkead, MA, LPC, LMFT Counselor Medicare: Not Enrolled in Medicare Practice Location: 20915 Kingsland Blvd, Katy, TX 77450 Phone: 281-579-0703 Fax: 281-398-9719 | |
David John Dotson, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 609 B Park Grove Drive, Katy, TX 77450 Phone: 281-277-8827 | |
Mr. Timothy Richmond Spears, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 1826 Snake River Rd Ste D, Katy, TX 77449 Phone: 281-394-1379 Fax: 281-712-2517 | |
Sonia L Fields-de Pass, MED, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 472 Park Grove Dr, Katy, TX 77450 Phone: 713-489-5473 | |
Nichelsea Gardner, LCDC Counselor Medicare: Not Enrolled in Medicare Practice Location: 1732 Katyland Dr, Katy, TX 77493 Phone: 281-237-6384 | |
Jessica Peralta, Counselor Medicare: Not Enrolled in Medicare Practice Location: 472 Park Grove Dr, Katy, TX 77450 Phone: 713-489-5473 |